Table 3 Comparative analysis of safety indexes of robotic surgery
KD-SR Group(n = 26) | DV Group(n = 24) | P-value | |
|---|---|---|---|
Duration of operation | <0.001 | ||
Median(Q1, Q3), min | 192.5(170.0, 221.3) | 155.0(141.3, 168.8) | |
Docking time | 0.140 | ||
Median(Q1, Q3), min | 5.3(4.2, 7.4) | 5.1(4.1, 5.9) | |
Console time | 0.022 | ||
Median(Q1, Q3), min | 68.3(56.4, 79.7) | 50.8(40.1, 67.6) | |
Blood loss | 0.297 | ||
Median(Q1, Q3), ml | 50.0(30.0, 50.0) | 50.0(50.0, 95.0) | |
Intraoperative transfusion, n | 0(0.0%) | 0(0.0%) | - |
Clavien-Dindo grade II or higher grade, n | 1(3.9%) | 2(8.3%) | 1.000 |
Adverse events, n | 7(26.9%) | 4(16.7%) | 0.382 |
Serious adverse events, n | 1(3.9%) | 2(8.3%) | 0.943 |
Postoperative hospital study, days | 0.684 | ||
Median(Q1, Q3), n | 8.0(7.0, 9.0) | 7.0 (7.0, 9.75) | |
Number of harvested lymph nodes | 0.835 | ||
Median(Q1, Q3), n | 13.5(12.0, 16.3) | 15.0(11.3, 16.8) | |
Negative margins, n | 51(98.08%) | 48(100%) | 1.000 |